X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Strides Arcolab with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs TEVA PHARMA (Israel) - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STRIDES SHASUN LTD   TEVA PHARMA
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
TEVA PHARMA
Dec-13
STRIDES SHASUN LTD/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,2752,929-   
Low Rs9182,545-   
Sales per share (Unadj.) Rs389.61,681.2-  
Earnings per share (Unadj.) Rs28.0105.0-  
Cash flow per share (Unadj.) Rs48.9240.9-  
Dividends per share (Unadj.) Rs4.5091.94-  
Dividend yield (eoy) %0.43.4 12.2%  
Book value per share (Unadj.) Rs303.11,867.5-  
Shares outstanding (eoy) m89.42848.00-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.81.6 172.9%   
Avg P/E ratio x39.226.1 150.4%  
P/CF ratio (eoy) x22.411.4 197.4%  
Price / Book Value ratio x3.61.5 246.8%  
Dividend payout %16.187.5 18.4%   
Avg Mkt Cap Rs m98,0362,320,993 4.2%   
No. of employees `0005.844.9 12.9%   
Total wages/salary Rs m5,8810-   
Avg. sales/employee Rs Th6,005.931,719.6 18.9%   
Avg. wages/employee Rs Th1,014.00-   
Avg. net profit/employee Rs Th431.21,981.5 21.8%   
INCOME DATA
Net Sales Rs m34,8341,425,637 2.4%  
Other income Rs m1,6860-   
Total revenues Rs m36,5201,425,637 2.6%   
Gross profit Rs m6,428390,411 1.6%  
Depreciation Rs m1,872115,236 1.6%   
Interest Rs m2,26928,002 8.1%   
Profit before tax Rs m3,973247,174 1.6%   
Minority Interest Rs m01,123 0.0%   
Prior Period Items Rs m40-   
Extraordinary Inc (Exp) Rs m-1,006-162,256 0.6%   
Tax Rs m470-3,018 -15.6%   
Profit after tax Rs m2,50189,058 2.8%  
Gross profit margin %18.527.4 67.4%  
Effective tax rate %11.8-1.2 -968.9%   
Net profit margin %7.26.2 114.9%  
BALANCE SHEET DATA
Current assets Rs m38,165962,870 4.0%   
Current liabilities Rs m30,402839,704 3.6%   
Net working cap to sales %22.38.6 258.0%  
Current ratio x1.31.1 109.5%  
Inventory Days Days7791 85.2%  
Debtors Days Days10496 108.9%  
Net fixed assets Rs m37,639465,644 8.1%   
Share capital Rs m8943,509 25.5%   
"Free" reserves Rs m26,2100-   
Net worth Rs m27,1051,583,612 1.7%   
Long term debt Rs m16,377728,960 2.2%   
Total assets Rs m81,1683,258,036 2.5%  
Interest coverage x2.89.8 28.0%   
Debt to equity ratio x0.60.5 131.3%  
Sales to assets ratio x0.40.4 98.1%   
Return on assets %5.93.6 163.6%  
Return on equity %9.25.6 164.1%  
Return on capital %12.14.9 244.4%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m9,3890-   
CASH FLOW
From Operations Rs m2,881227,173 1.3%  
From Investments Rs m-7,051-80,496 8.8%  
From Financial Activity Rs m3,382-272,509 -1.2%  
Net Cashflow Rs m-788-125,833 0.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 70.18 Rs / USD

Compare STRIDES SHASUN LTD With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare STRIDES SHASUN LTD With: WYETH LTD  SHASUN PHARMA  PIRAMAL ENTERPRISES  TORRENT PHARMA  ALEMBIC LTD  



Today's Market

Sensex Ends 284 Points Up; FMCG & Metal Stocks Top Gainers(Closing)

Indian share markets settled higher today taking cues from their Asian peers. At the closing bell, BSE Sensex ended up by 284 points.

Related Views On News

STRIDES SHASUN LTD Announces Quarterly Results (1QFY19); Net Profit Down 57.5% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, STRIDES SHASUN LTD has posted a net profit of Rs 38 m (down 57.5% YoY). Sales on the other hand came in at Rs 7 bn (down 21.2% YoY). Read on for a complete analysis of STRIDES SHASUN LTD's quarterly results.

STRIDES SHASUN LTD Announces Quarterly Results (4QFY18); Net Profit Down 99.2% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, STRIDES SHASUN LTD has posted a net profit of Rs 8 m (down 99.2% YoY). Sales on the other hand came in at Rs 7 bn (down 25.2% YoY). Read on for a complete analysis of STRIDES SHASUN LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Banks are Raising FD Rates and That's Good News(Vivek Kaul's Diary)

Aug 7, 2018

Lending to the retail segment remains strong, whereas lending to the service sector has picked up dramatically.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


Aug 17, 2018 (Close)

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD - MERCK LTD COMPARISON

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS